• About us
• Contact

Advertisement

Organisation › Details

Brammer Bio LLC

Brammer Bio provides clinical and commercial supply of vectors for in vivo gene therapy and ex vivo gene-modified cell therapy, along with process and analytical development, and regulatory support, enabling large pharma and biotech clients to accelerate the delivery of novel medicines to improve patients' health. Brammer is Helping to Cure®. Brammer is owned by Ampersand Capital Partners, the only institutional investor in the company, and its founders. *

 

	Start	2017-12-09 existent
	Group	Thermo Fisher (Group)
	Industry	cell therapy
	Region	Cambridge, MA
	Country	United States (USA)
	Street	250 Binney Street
	City	02142 Cambridge, MA
		Address record changed: 2020-12-02
Basic data	Employees	E: 501 to 1,000 (2019-03-24)
	Currency	USD
	Annual sales	250,000,000 (revenue, expected (2019) 2019-12-31)
		* Document for »About Section«: Thermo Fisher Scientific Inc.. (3/24/19). "Press Release: Thermo Fisher Scientific to Acquire Brammer Bio, a Leader in Viral Vector Manufacturing". Waltham, MA & Cambridge, MA.
		Record changed: 2024-06-07

Advertisement

More documents for Thermo Fisher (Group)

• [1] Thermo Fisher Scientific Inc.. (10/29/25). "Press Release: Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights". Waltham, MA....
• [2] Tecan Group Ltd.. (7/10/25). "Press Release: Tecan Announces CEO Transition as Part of Succession Planning". Männedorf....
• [3] Thermo Fisher Scientific Inc.. (2/25/25). "Press Release: Thermo Fisher Scientific to Acquire Solventum’s Purification and Filtration Business". Waltham, MA....
• [4] miDiagnostics N.V.. (12/4/24). "Press Release: miDiagnostics Secures €30 Million Series D Funding Round Led by Thermo Fisher Scientific to Advance an Innovative Sterility Test and Other Quality Control Tests for use in the BioPharma Industry". Leuven....
• [5] Broken String Biosciences Ltd.. (7/24/24). "Press Release: Broken String Biosciences Appoints Steve Becker as Chief Commercial Officer". Cambridge....
• [6] Tecan Group Ltd.. (6/24/24). "Press Release: Tecan Appoints Mukta Acharya Head of the Life Sciences Business Division". Männedorf....
• [7] Thermo Fisher Scientific Inc.. (10/17/23). "Press Release: Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics". Waltham, MA & Uppsala....
• [8] Evosep ApS. (9/28/23). "Press Release: Evosep Strengthens Leadership to Drive Scale-up". Odense....
• [9] Thermo Fisher Scientific Inc.. (10/31/22). "Press Release: Thermo Fisher Scientific to Acquire The Binding Site Group". Waltham, MA....
• [10] Thermo Fisher Scientific Inc.. (1/4/22). "Press Release: Thermo Fisher Scientific to Present at the 40th Annual J.P. Morgan Healthcare Conference". Waltham, MA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.